AHG vs BHC
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
AHG's Piotroski F-Score of 5/9 indicates a stable but not strong financial position, with significant red flags in profitability and cash flow. The company reports a 0.00% profit margin, negative ROE of -68.29%, and a gross margin of just 1.00%, signaling deep operational inefficiencies. Despite a low debt/equity ratio and decent liquidity, the absence of positive earnings, free cash flow, and a lack of dividend support undermine long-term sustainability. The stock's price performance is driven by speculative momentum rather than fundamentals, with a Price/Sales of 144.30 far exceeding sector averages and no intrinsic value support.
The deterministic health scores paint a concerning picture, with a Piotroski F-Score of 4/9 indicating marginal financial stability and no Altman Z-Score available to confirm solvency, raising red flags. Despite a low P/E of 6.79 and forward P/E of 1.41 suggesting potential undervaluation, the negative Price/Book ratio (-3.88) implies serious equity deficiencies or accumulated losses. Strong operating and gross margins contrast sharply with a sky-high Debt/Equity ratio of 59.11, indicating extreme leverage risk. Insider selling, weak technical trend (0/100), and a 5-year price decline of 78.1% further underscore investor skepticism and structural challenges.
Compare Another Pair
Related Comparisons
AHG vs BHC: Head-to-Head Comparison
This page compares Akso Health Group (AHG) and Bausch Health Companies Inc. (BHC) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.